Results Snapshot
Figures in Million
Consolidate Annual Results
Dec'25
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
Net Sales
1,123.44
1,286.91
1,308.61
1,383.25
1,021.68
706.99
733.06
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
1,123.44
1,286.91
1,308.61
1,383.25
1,021.68
706.99
733.06
Raw Material Cost
469.50
632.61
693.72
700.14
531.78
411.27
417.19
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
179.54
174.79
156.88
110.13
62.79
61.50
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
0.31
0.31
0.43
0.28
2.07
1.29
0.00
Selling and Distribution Expenses
339.32
328.95
375.84
456.23
364.03
236.24
251.11
Other Expenses
9.37
-8.32
-7.95
-9.40
-7.87
-4.35
-3.49
Total Expenditure (Excl Depreciation)
902.80
1,058.20
1,165.31
1,219.53
929.27
668.10
694.86
Operating Profit (PBDIT) excl Other Income
220.6
228.70000000000002
143.3
163.70000000000002
92.4
38.9
38.199999999999996
Other Income
48.68
69.60
61.41
41.40
28.57
31.92
26.61
Operating Profit (PBDIT)
265.29
350.68
255.03
249.70
155.27
103.74
94.38
Interest
0.31
0.31
0.43
0.28
2.07
1.29
0.00
Exceptional Items
18.62
-19.25
11.58
-24.01
-2.83
0.00
-0.22
Gross Profit (PBDT)
653.94
654.30
614.89
683.11
489.90
295.71
315.87
Depreciation
0.00
54.52
50.34
43.06
36.14
32.83
28.24
Profit Before Tax
283.60
276.60
215.84
182.36
114.23
69.62
65.93
Tax
50.75
30.43
1.82
5.40
18.32
11.20
10.25
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
232.85
246.17
214.02
176.96
95.91
58.42
55.68
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
232.85
246.17
214.02
176.96
95.91
58.42
55.68
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
232.85
246.17
214.02
176.96
95.91
58.42
55.68
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
0.0
1.0
1.0
1.0
1.0
1.0
1.0
Reserves
1,476.37
1,385.44
1,340.35
1,220.59
1,067.26
983.21
930.05
Earnings per share (EPS)
0.54
0.57
0.5
0.41
0.23
0.14
0.13
Diluted Earnings per share
0.54
0.57
0.5
0.41
0.23
0.14
0.13
Operating Profit Margin (Excl OI)
19.28%
17.6%
10.95%
11.95%
8.86%
5.52%
5.39%
Gross Profit Margin
25.24%
25.73%
20.34%
16.3%
14.72%
14.49%
12.85%
PAT Margin
20.73%
19.13%
16.35%
12.79%
9.39%
8.26%
7.6%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
Net Sales
YoY Growth in year ended Dec 2025 is -12.70% vs -1.66% in Dec 2024
Consolidate Net Profit
YoY Growth in year ended Dec 2025 is -5.40% vs 15.05% in Dec 2024
Operating Profit (PBDIT) excl Other Income
YoY Growth in year ended Dec 2025 is -22.95% vs 45.20% in Dec 2024
Interest
YoY Growth in year ended Dec 2025 is 0.00% vs -25.00% in Dec 2024
Operating Profit Margin (Excl OI)
YoY Growth in year ended Dec 2025 has improved from Dec 2024
Compare Annual Results Of Tibet Weixinkang Medicine Co., Ltd. With
Figures in Million
Consolidate Annual Results
Change(CNY)
Change(%)
Net Sales
1,123.44
0
1,123.44
Other Operating Income
0.00
0.00
0.00
Total Operating income
1,123.44
0
1,123.44
Raw Material Cost
469.50
0
469.50
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
0.31
0
0.31
Selling and Distribution Expenses
339.32
0
339.32
Other Expenses
9.37
0.00
9.37
Total Expenditure (Excl Depreciation)
902.80
0
902.80
Operating Profit (PBDIT) excl Other Income
220.64
0.00
220.64
Other Income
48.68
0
48.68
Operating Profit (PBDIT)
265.29
0
265.29
Interest
0.31
0
0.31
Exceptional Items
18.62
0
18.62
Gross Profit (PBDT)
653.94
0
653.94
Depreciation
0.00
0
0.00
Profit Before Tax
283.60
0
283.60
Tax
50.75
0
50.75
Provisions and contingencies
0
0
0.00
Profit After Tax
232.85
0
232.85
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
232.85
0
232.85
Share in Profit of Associates
0
0
0.00
Minority Interest
0.00
0
0.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
232.85
0
232.85
Equity Capital
0
0
0.00
Face Value
0.00
0
0.00
Reserves
1,476.37
0
1,476.37
Earnings per share (EPS)
0.54
0
0.54
Diluted Earnings per share
0.54
0
0.54
Operating Profit Margin (Excl OI)
19.28%
0%
0.00
19.28%
Gross Profit Margin
25.24%
0%
0.00
25.24%
PAT Margin
20.73%
0%
0.00
20.73%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Annual - Net Sales
Net Sales 112.34 Million
in Dec 2025Figures in Million
YoY Growth in year ended Dec 2025 is -12.70% vs -1.66% in Dec 2024
Annual - Consolidate Net Profit
Consolidate Net Profit 23.29 Million
in Dec 2025Figures in Million
YoY Growth in year ended Dec 2025 is -5.40% vs 15.05% in Dec 2024
Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 21.66 Million
in Dec 2025Figures in Million
YoY Growth in year ended Dec 2025 is -22.95% vs 45.20% in Dec 2024
Annual - Interest
Interest 0.03 Million
in Dec 2025Figures in Million
YoY Growth in year ended Dec 2025 is 0.00% vs -25.00% in Dec 2024
Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 19.28%
in Dec 2025Figures in %
YoY Growth in year ended Dec 2025 has improved from Dec 2024






